Revvity, Inc. (NYSE:RVTY) Shares Sold by Simplify Asset Management Inc.

Simplify Asset Management Inc. lessened its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 34.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,920 shares of the company’s stock after selling 8,383 shares during the period. Simplify Asset Management Inc.’s holdings in Revvity were worth $1,777,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Empowered Funds LLC acquired a new stake in Revvity during the 3rd quarter worth $227,000. Natixis Advisors LLC increased its position in shares of Revvity by 17.9% during the third quarter. Natixis Advisors LLC now owns 12,499 shares of the company’s stock worth $1,597,000 after purchasing an additional 1,901 shares in the last quarter. Quest Partners LLC purchased a new stake in shares of Revvity in the 3rd quarter valued at about $126,000. Pathstone Holdings LLC boosted its position in shares of Revvity by 70.0% in the 3rd quarter. Pathstone Holdings LLC now owns 21,358 shares of the company’s stock valued at $2,728,000 after purchasing an additional 8,791 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Revvity during the 3rd quarter worth approximately $393,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Price Performance

Shares of NYSE:RVTY opened at $107.18 on Friday. The firm has a market capitalization of $12.88 billion, a price-to-earnings ratio of 48.50, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The business’s 50 day simple moving average is $116.44 and its 200-day simple moving average is $117.54. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50.

Revvity (NYSE:RVTY) last posted its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the prior year, the business earned $1.25 EPS. As a group, equities analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s payout ratio is currently 12.67%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on RVTY shares. Barclays increased their price objective on Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. KeyCorp raised their price objective on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Sanford C. Bernstein cut shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a report on Friday, January 10th. Raymond James reissued an “outperform” rating and set a $145.00 price target (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Finally, Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective for the company in a research note on Friday, December 13th. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $136.25.

Insider Buying and Selling at Revvity

In related news, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the transaction, the insider now owns 19,652 shares of the company’s stock, valued at approximately $2,295,550.12. The trade was a 21.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares in the company, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.60% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.